Cargando…
P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431272/ http://dx.doi.org/10.1097/01.HS9.0000847780.61937.3d |
| _version_ | 1784780007994818560 |
|---|---|
| author | Vassilakopoulos, T. Ferhanoglu, B. Horowitz, N. A. Apostolidis, J. Mellios, Z. Kaynar, L. Zektser, M. Symeonidis, A. Piperidou, A. Kalpadaki, C. Akay, O. M. Atalar, S. C. Sayyed, A. Katodritou, E. Leonidopoulou, T. Papageorgiou, S. Tadmor, T. Gutwein, O. Karakatsanis, S. Ganzel, C. Karianakis, G. Isenberg, G. Gainaru, G. Vrakidou, E. Palassopoulou, M. Ozgur, M. Siakantaris, M. Paydas, S. Tsirigotis, P. Tsirogianni, M. Hatzimichael, E. Tuglular, T. F. Chatzidimitriou, C. Liaskas, A. Lefaki, M. A. Kanellias, N. Zikos, P. Koumarianou, A. Gafter-Gvili, A. Angelopoulou, M. Karmiris, T. Gurion, R. |
| author_facet | Vassilakopoulos, T. Ferhanoglu, B. Horowitz, N. A. Apostolidis, J. Mellios, Z. Kaynar, L. Zektser, M. Symeonidis, A. Piperidou, A. Kalpadaki, C. Akay, O. M. Atalar, S. C. Sayyed, A. Katodritou, E. Leonidopoulou, T. Papageorgiou, S. Tadmor, T. Gutwein, O. Karakatsanis, S. Ganzel, C. Karianakis, G. Isenberg, G. Gainaru, G. Vrakidou, E. Palassopoulou, M. Ozgur, M. Siakantaris, M. Paydas, S. Tsirigotis, P. Tsirogianni, M. Hatzimichael, E. Tuglular, T. F. Chatzidimitriou, C. Liaskas, A. Lefaki, M. A. Kanellias, N. Zikos, P. Koumarianou, A. Gafter-Gvili, A. Angelopoulou, M. Karmiris, T. Gurion, R. |
| author_sort | Vassilakopoulos, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431272 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312722022-08-31 P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES Vassilakopoulos, T. Ferhanoglu, B. Horowitz, N. A. Apostolidis, J. Mellios, Z. Kaynar, L. Zektser, M. Symeonidis, A. Piperidou, A. Kalpadaki, C. Akay, O. M. Atalar, S. C. Sayyed, A. Katodritou, E. Leonidopoulou, T. Papageorgiou, S. Tadmor, T. Gutwein, O. Karakatsanis, S. Ganzel, C. Karianakis, G. Isenberg, G. Gainaru, G. Vrakidou, E. Palassopoulou, M. Ozgur, M. Siakantaris, M. Paydas, S. Tsirigotis, P. Tsirogianni, M. Hatzimichael, E. Tuglular, T. F. Chatzidimitriou, C. Liaskas, A. Lefaki, M. A. Kanellias, N. Zikos, P. Koumarianou, A. Gafter-Gvili, A. Angelopoulou, M. Karmiris, T. Gurion, R. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431272/ http://dx.doi.org/10.1097/01.HS9.0000847780.61937.3d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Vassilakopoulos, T. Ferhanoglu, B. Horowitz, N. A. Apostolidis, J. Mellios, Z. Kaynar, L. Zektser, M. Symeonidis, A. Piperidou, A. Kalpadaki, C. Akay, O. M. Atalar, S. C. Sayyed, A. Katodritou, E. Leonidopoulou, T. Papageorgiou, S. Tadmor, T. Gutwein, O. Karakatsanis, S. Ganzel, C. Karianakis, G. Isenberg, G. Gainaru, G. Vrakidou, E. Palassopoulou, M. Ozgur, M. Siakantaris, M. Paydas, S. Tsirigotis, P. Tsirogianni, M. Hatzimichael, E. Tuglular, T. F. Chatzidimitriou, C. Liaskas, A. Lefaki, M. A. Kanellias, N. Zikos, P. Koumarianou, A. Gafter-Gvili, A. Angelopoulou, M. Karmiris, T. Gurion, R. P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES |
| title | P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES |
| title_full | P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES |
| title_fullStr | P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES |
| title_full_unstemmed | P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES |
| title_short | P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES |
| title_sort | p1229: rituximab-dose-adjusted epoch (r-da-epoch) in primary mediastinal large b-cell lymphoma (pmlbcl): real-life experience on 225 patients from 4 countries |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431272/ http://dx.doi.org/10.1097/01.HS9.0000847780.61937.3d |
| work_keys_str_mv | AT vassilakopoulost p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT ferhanoglub p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT horowitzna p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT apostolidisj p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT melliosz p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT kaynarl p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT zektserm p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT symeonidisa p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT piperidoua p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT kalpadakic p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT akayom p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT atalarsc p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT sayyeda p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT katodritoue p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT leonidopoulout p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT papageorgious p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT tadmort p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT gutweino p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT karakatsaniss p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT ganzelc p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT karianakisg p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT isenbergg p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT gainarug p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT vrakidoue p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT palassopouloum p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT ozgurm p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT siakantarism p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT paydass p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT tsirigotisp p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT tsirogiannim p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT hatzimichaele p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT tuglulartf p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT chatzidimitriouc p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT liaskasa p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT lefakima p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT kanelliasn p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT zikosp p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT koumarianoua p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT gaftergvilia p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT angelopouloum p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT karmirist p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries AT gurionr p1229rituximabdoseadjustedepochrdaepochinprimarymediastinallargebcelllymphomapmlbclreallifeexperienceon225patientsfrom4countries |